Microbot Medical Inc. (MBOT)
MBOT moved a median of -0.19% 30 minutes after news, and -0.69% by the close. How MBOT actually reacts to news — the realized, point-in-time move the market made, measured across 366 labeled events over the last three years with zero look-ahead.
MBOT’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 45% | 365 |
| 30-min | -0.19% | 43% | 366 |
| 60-min | -0.55% | 40% | 366 |
| to close | -0.69% | 42% | 363 |
| Middle 50% of MBOT reactions | -2.21% to +1.68% |
|---|---|
| Median reaction (30-min) | -0.19% |
| Measured reactions | 366 |
Half of all Microbot Medical Inc. news events land between -2.21% and +1.68% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How MBOT reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 10 | -2.07% | 10% | +2.50% |
| Rating reiterations | 22 | +1.25% | 64% | 0.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how MBOT ranks against every other measured name →
That’s how MBOT usually reacts — get an email when it moves on news →Email me when MBOT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MBOT's baseline. Nothing else.
Recent MBOT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Microbot Medical Inc. For: Oct 06 | SEC filing · Form 8-K | SEC EDGAR | +0.92% | -1.83% | |
| Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel | Press release | GlobeNewswire | +0.92% | -1.83% | |
| Form 8-K Microbot Medical Inc. For: Sep 25 | SEC filing · Form 8-K | SEC EDGAR | -0.39% | -1.57% | |
| Microbot Medical® Highlights Growth Strategy | Press release | GlobeNewswire | -0.39% | -1.57% | |
| Form 10-Q Microbot Medical Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.12% | -11.11% | |
| Form 8-K Microbot Medical Inc. For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | -0.06% | -2.32% | |
| Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter | Press release | GlobeNewswire | -2.12% | -11.11% | |
| Form 8-K Microbot Medical Inc. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +0.53% | — | |
| Form 8-K Microbot Medical Inc. For: Jul 21 | SEC filing · Form 8-K | SEC EDGAR | +1.12% | +1.12% | |
| Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting | Press release | GlobeNewswire | +1.12% | +1.12% | |
| Form 8-K Microbot Medical Inc. For: Jul 07 | SEC filing · Form 8-K | SEC EDGAR | +0.51% | -3.55% | |
| Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026 | Press release | GlobeNewswire | +0.51% | -3.55% | |
| Form 8-K Microbot Medical Inc. For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | +2.66% | +3.72% | |
| Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader | Press release | GlobeNewswire | +2.66% | +3.72% | |
| Form 8-K Microbot Medical Inc. For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | -0.83% | -2.21% | |
| Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System | Press release | GlobeNewswire | -0.83% | -2.21% | |
| Form 8-K Microbot Medical Inc. For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | +1.68% | +1.68% | |
| Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System | Press release | GlobeNewswire | +1.68% | +1.68% | |
| Form 8-K Microbot Medical Inc. For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | -0.27% | -2.15% | |
| Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations | Press release | GlobeNewswire | -0.27% | -2.15% | |
| Form 8-K Microbot Medical Inc. For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | -0.49% | -2.15% | |
| Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System | Press release | GlobeNewswire | -0.49% | -2.15% | |
| Form 8-K Microbot Medical Inc. For: Jun 02 | SEC filing · Form 8-K | SEC EDGAR | -0.76% | +1.51% | |
| Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System | Press release | GlobeNewswire | -0.76% | +1.51% | |
| Form 8-K Microbot Medical Inc. For: May 26 | SEC filing · Form 8-K | SEC EDGAR | +3.65% | +1.69% | |
| Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System | Press release | GlobeNewswire | +3.65% | +1.69% | |
| Form 8-K Microbot Medical Inc. For: May 15 | SEC filing · Form 8-K | SEC EDGAR | -0.52% | -3.39% | |
| Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu | Press release | GlobeNewswire | -1.00% | -1.60% | |
| Form 8-K Microbot Medical Inc. For: May 14 | SEC filing · Form 8-K | SEC EDGAR | -7.48% | -13.55% | |
| Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 | Press release | GlobeNewswire | -7.48% | -13.55% | |
| Form 10-Q Microbot Medical Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -7.48% | -13.55% | |
| Form 8-K Microbot Medical Inc. For: May 05 | SEC filing · Form 8-K | SEC EDGAR | -0.94% | -1.41% | |
| Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites | Press release | GlobeNewswire | -0.94% | -1.41% | |
| Form 8-K Microbot Medical Inc. For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.70% | |
| Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA) | Press release | GlobeNewswire | +0.49% | +2.45% | |
| Form 8-K Microbot Medical Inc. For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | -0.20% | +1.83% | |
| Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY® | Press release | GlobeNewswire | -0.20% | +1.83% | |
| Form 8-K Microbot Medical Inc. For: Apr 14 | SEC filing · Form 8-K | SEC EDGAR | +3.32% | +0.83% | |
| Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference | Press release | GlobeNewswire | +1.05% | +1.67% | |
| Form 8-K Microbot Medical Inc. For: Apr 13 | SEC filing · Form 8-K | SEC EDGAR | -1.08% | +0.00% | |
| Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting | Press release | GlobeNewswire | -1.08% | +0.00% | |
| Form 8-K Microbot Medical Inc. For: Apr 10 | SEC filing · Form 8-K | SEC EDGAR | -1.08% | +0.00% | |
| Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System | Press release | GlobeNewswire | +1.83% | -2.24% | |
| Form 10-K Microbot Medical Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.17% | -7.00% | |
| Form 8-K Microbot Medical Inc. For: Mar 26 | SEC filing · Form 8-K | SEC EDGAR | +1.83% | -2.24% | |
| Form 8-K Microbot Medical Inc. For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | +0.73% | -0.79% | |
| Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal | Press release | GlobeNewswire | +0.73% | -0.79% | |
| Form 8-K Microbot Medical Inc. For: Mar 17 | SEC filing · Form 8-K | SEC EDGAR | +0.73% | +1.10% | |
| Microbot Medical® to Participate at the 38th Annual Roth Conference | Press release | GlobeNewswire | +0.73% | +1.10% | |
| Form 8-K Microbot Medical Inc. For: Mar 10 | SEC filing · Form 8-K | SEC EDGAR | +3.23% | +1.61% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MBOT section they belong to.
Where else MBOT is measured.
MBOT earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | 368 | -0.09% | 45% |
| Ligand Pharmaceuticals Incorporated (LGND) | 367 | +0.06% | 52% |
| SOPHIRIS BIO INC (SPHS) | 366 | -0.23% | 37% |
| EISAI CO S/ADR (ESALY) | 365 | 0.00% | 33% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Microbot Medical Inc.'s median reaction calculated?
Every labeled MBOT news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 366 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 43% of MBOT's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MBOT's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.